Reuters logo
BRIEF-Nymox expects submission of initial filing seeking approval for Fexapotide Triflutate in next few weeks
March 29, 2017 / 2:55 PM / 6 months ago

BRIEF-Nymox expects submission of initial filing seeking approval for Fexapotide Triflutate in next few weeks

March 29 (Reuters) - Nymox Pharmaceutical Corp:

* Nymox provides update on Fexapotide development

* “Now expects to submit its initial filing seeking approval for Fexapotide Triflutate in next few weeks” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below